EUVIMEDEUVIMED entdecken
Open Access

Highly Efficient Enzymatic Catalytic Transformation for the Synthesis of Rare Ginsenoside Compound K (CK) and Its Bioactivity Study

Hao Tang, Shihua Han, Zidan Li, Yiwen Jiang, Meimei Fu, Zhuoyi Huang, Lei Jia, Fengrui Song, Jianguo Huang, Gloria B Kim iD, Jinshan Guo iD, Zhihui Lu

Biotechnology and Bioengineering · 2026

DOI: 10.1002/bit.70277 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biotechnology and Bioengineering, 2026. Verfasst von Hao Tang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Suzhou Zhentai Biotechnology Co., Ltd, Kunshan Industrial Technology Research Institute, Suzhou, P. R. China. Hauptthemen laut MEDLINE: Ginsenosides, Escherichia coli, beta-Glucosidase, Metabolic Engineering. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As a principal metabolite of ginsenosides, compound K (CK) exhibits remarkable antioxidant, anti‐inflammatory, antidiabetic, and anticancer bioactivities. However, CK is naturally scarce in ginseng and its industrial application is limited by the lack of efficient deglycosylating enzymes for large‐scale CK bioproduction. Here, we report a synthetic biology‐driven approach for high‐yield CK production via recombinant β‐glycosidase‐mediated bioconversion of the polar ginsenoside Rb1. The β‑glycosidase‐encoding gene was introduced into Escherichia coli BL21 (DE3), and the resulting engineered strain produced 2.1 g/L β‑glycosidase in shake flasks and 10.1 g/L in a 5‐L fermentor. The crude β‐glycosidase exhibited excellent enzymatic activity; at a concentration of 1.5 g/L, it converted 95% of the Rb1 substrate (initial concentration 10 g/L) to CK within 4 h. In vitro studies demonstrated CK's high cytocompatibility and potent anti‐aging effects, including suppression of reactive oxygen species ( via upregulation of superoxide dismutase, catalase, and glutathione peroxidase), enhanced collagen I, Ⅲ and elastin synthesis, and matrix metalloproteinase‐1 inhibition. These findings highlight CK as a promising candidate for anti‐wrinkle formulations, supported by the feasibility of scalable bioproduction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GinsenosidesEscherichia colibeta-GlucosidaseMetabolic EngineeringRecombinant ProteinsPanax

Stichwörter der Autor:innen

anti‐agingbioconversioncompound CKginsenoside Rb1recombinant β‑glycosidase

Substanzen

Ginsenosidesginsenoside compound KRecombinant Proteinsbeta-Glucosidaseginsenoside Rb1

Autor:innen und Institutionen

  • Suzhou Zhentai Biotechnology Co., Ltd, Kunshan Industrial Technology Research Institute, Suzhou, P. R. China.
  • Dongguan Qingxi Hospital, Dongguan City, P. R. China.
  • Department of Biomaterials and Stem Cells, Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Science, Suzhou, P. R. China.
  • Regenerative Medicine and Tissue Repair Research Center, Huangpu Institute of Materials, Guangzhou, P. R. China.
  • Department of Physiology and Biomedical Engineering, Department of Immunology, Mayo Clinic Arizona, Scottsdale, Arizona, USA.

ORCID-Profile: Gloria B Kim, Jinshan Guo

Zitieren

APA

Tang, H., Han, S., Li, Z., Jiang, Y., Fu, M., Huang, Z., Jia, L., Song, F., Huang, J., Kim, G. B., Guo, J., & Lu, Z. (2026). Highly Efficient Enzymatic Catalytic Transformation for the Synthesis of Rare Ginsenoside Compound K (CK) and Its Bioactivity Study. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.70277

Vancouver

Tang H, Han S, Li Z, Jiang Y, Fu M, Huang Z, et al. Highly Efficient Enzymatic Catalytic Transformation for the Synthesis of Rare Ginsenoside Compound K (CK) and Its Bioactivity Study. Biotechnology and Bioengineering. 2026. doi:10.1002/bit.70277

BibTeX
@article{Tang2026,
  author = {Tang, Hao and Han, Shihua and Li, Zidan and Jiang, Yiwen and Fu, Meimei and Huang, Zhuoyi and Jia, Lei and Song, Fengrui and Huang, Jianguo and Kim, Gloria B and Guo, Jinshan and Lu, Zhihui},
  title = {Highly Efficient Enzymatic Catalytic Transformation for the Synthesis of Rare Ginsenoside Compound K (CK) and Its Bioactivity Study},
  journal = {Biotechnology and Bioengineering},
  year = {2026},
  doi = {10.1002/bit.70277}
}
Kostenlos starten →